Also found in: Thesaurus, Legal, Acronyms, Idioms, Encyclopedia, Wikipedia.


n. pl. aus·pi·ces (ô′spĭ-sēz′)
An augur of ancient Rome, especially one who interpreted omens derived from the observation of birds.

[Latin; see auspice.]


n, pl auspices (ˈɔːspɪˌsiːz)
(Historical Terms) Roman history another word for augur1
[C16: from Latin: observer of birds, from avis bird + specere to look]


(ˈɔ spɛks)

n., pl. aus•pi•ces (ˈɔ spəˌsiz)
an augur of ancient Rome.
[1590–1600; < Latin: one who observes birds, augur =au-, base of avis bird + spec(ere) to look at + -s nominative singular suffix]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.auspex - (ancient Rome) a religious official who interpreted omens to guide public policyauspex - (ancient Rome) a religious official who interpreted omens to guide public policy
capital of Italy, Eternal City, Italian capital, Rome, Roma - capital and largest city of Italy; on the Tiber; seat of the Roman Catholic Church; formerly the capital of the Roman Republic and the Roman Empire
oracle, prophesier, prophet, vaticinator, seer - an authoritative person who divines the future
antiquity - the historic period preceding the Middle Ages in Europe


A person who foretells future events by or as if by supernatural means:
References in periodicals archive ?
Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Auspex Pharmaceuticals Inc.
If you own shares of Auspex and would like to learn more about the Auspex investigation, you may contact Morgan & Morgan at 1(800) 732-5200 or email info@morgansecuritieslaw.
Our NS3000 product family has been engineered to meet the diverse storage needs of different enterprises as well as to move toward a universal storage management solution that overcomes the inefficiencies and extra expense of today's vendor-specific storage strategies," said Mike Worhach, President of Auspex Systems.
The Auspex NSc3000 and NSc3000V provide industry-leading performance in excess of 19,700 IOPS in UNIX environments as well as the ability to support thousands of users simultaneously, making the platform suitable both for mid-tier applications and for large enterprise deployments.
Auspex Pharmaceuticals has announced that it has been developing a deuterium containing levodopa, SD-1077, in partnership with Imphar AG, a German drug developer, and it has signed a stock purchase agreement (SPA) to buy the remaining rights to SD-1077, and related intellectual property, by acquiring Imphar AG.
Auspex is also recruiting general IT services firms such as Sayers Group, a 20-year technology consultant and solutions provider with offices across the country.
Thomas Garofalo, Vice President & General Manager of Auspex Asia Pacific, said: "I am excited that the Auspex NSc3000 is available to researchers and students in Singapore's premier storage research centre.
Partner with Panorama Capital, has joined the Auspex Board of Directors.
Under the terms of the transaction, Auspex Pharmaceuticals shareholders will receive $101 in cash for each share of Auspex Pharmaceuticals stock they own.
Auspex Pharmaceuticals, a developer of next-generation medicines with improved safety and performance through the targeted deuteration of clinically validated drugs, today announced positive results from its Phase 1 clinical trial evaluating SD-254, a Selective Serotinin-Norepinephrine Reuptake Inhibitor (SNRI).
If you own shares of Auspex stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.
If you own shares of Auspex and would like to learn more about this class action or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A.